Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIOUS-B methotrexate tapering study in rheumatoid arthritis with stable low disease activity on baricitinib
jRCT1041190125Completed
- Sponsor
- Nagoya University Hospital
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of baricitinib and methotrexate in rheumatoid arthritis (RA), sponsored by Nagoya University Hospital. Primary endpoint: Maintenance of low disease activity without flare at week 36. Started Mar 2020; status: completed.
02
Drugs
baricitinibmethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1041190125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041190125.